Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men

被引:196
作者
Bouché, C
Rizkalla, SW
Luo, J
Vidal, H
Veronese, A
Pacher, N
Fouquet, C
Lang, V
Slama, G
机构
[1] Hop Hotel Dieu AP, INSERM U341, Dept Diabet, F-75004 Paris, France
[2] INSERM U449, Lyon, France
[3] Danone Vitapole, Le Plessis Robinson, France
关键词
D O I
10.2337/diacare.25.5.822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To evaluate whether a 5-week low-glycemic index (LGI) diet versus a high-glycemic index (HGI) diet can modify glucose and lipid metabolism as well as total fat mass in nondiabetic men. RESEARCH DESIGN AND METHODS - in this study, 11 healthy men were randomly allocated to 5 weeks of an LGI or HGI diet separated by a 5-week washout interval in a crossover design. RESULTS - The LGI diet resulted in lower postprandial plasma glucose and insulin profiles and areas under the curve (AUCs) than the HGI diet. A 5-week period of the LGI diet lowered plasma triacylglycerol excursion after lunch (AUC, P < 0.05 LGI vs. HGI). These modifications were associated with a decrease in the total fat mass by similar to700 g (P < 0.05) and a tendency to increase lean body mass (P < 0.07) without any change in body weight. This decrease in fat mass was accompanied by a decrease in leptin, lipoprotein lipase, and hormone-sensitive lipase RNAm quantities in the subcutaneous abdominal adipose tissue (P < 0.05). CONCLUSIONS - We concluded that 5 weeks of an LGI diet ameliorates some plasma lipid parameters, decreases total fat mass, and tends to increase lean body mass without changing body weight. These changes were accompanied by a decrease in the expression of some genes implicated in lipid metabolism. Such a diet could be of benefit to healthy, slightly overweight subjects and might play a role in the prevention of metabolic diseases and their cardiovascular complications.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 32 条
  • [1] Agus MSD, 2000, AM J CLIN NUTR, V71, P901
  • [2] *AM DIAB ASS, 1999, DIABETES CARE S, V1, P42
  • [3] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
    Auboeuf, D
    Rieusset, J
    Fajas, L
    Vallier, P
    Frering, V
    Riou, JP
    Staels, P
    Auwerx, J
    Laville, M
    Vidal, H
    [J]. DIABETES, 1997, 46 (08) : 1319 - 1327
  • [4] DIETS CONTAINING HIGH AMYLOSE VS AMYLOPECTIN STARCH - EFFECTS ON METABOLIC VARIABLES IN HUMAN-SUBJECTS
    BEHALL, KM
    SCHOLFIELD, DJ
    YUHANIAK, I
    CANARY, J
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 49 (02) : 337 - 344
  • [5] EFFECT OF LONG-TERM CONSUMPTION OF AMYLOSE VS AMYLOPECTIN STARCH ON METABOLIC VARIABLES IN HUMAN-SUBJECTS
    BEHALL, KM
    HOWE, JC
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 61 (02) : 334 - 340
  • [6] POSTPRANDIAL MODULATION OF LIPOPROTEIN-LIPASE IN RATS WITH INSULIN-RESISTANCE
    BOIVIN, A
    MONTPLAISIR, I
    DESHAIES, Y
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1994, 267 (04): : E620 - E627
  • [7] LOW-GLYCEMIC INDEX FOODS IMPROVE LONG-TERM GLYCEMIC CONTROL IN NIDDM
    BRAND, JC
    COLAGIURI, S
    CROSSMAN, S
    ALLEN, A
    ROBERTS, DCK
    TRUSWELL, AS
    [J]. DIABETES CARE, 1991, 14 (02) : 95 - 101
  • [8] Brand Miller J., 1996, GI FACTOR
  • [9] BYRNES SE, 1995, J NUTR, V125, P1430
  • [10] DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214